Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Performance of the platelet function analyser PFA-100 in testing abnormalities of primary haemostasis.

Harrison P, Robinson MS, Mackie IJ, Joseph J, McDonald SJ, Liesner R, Savidge GF, Pasi J, Machin SJ.

Blood Coagul Fibrinolysis. 1999 Jan;10(1):25-31.

PMID:
10070832
2.

The PFA-100: a potential rapid screening tool for the assessment of platelet dysfunction.

Harrison P, Robinson M, Liesner R, Khair K, Cohen H, Mackie I, Machin S.

Clin Lab Haematol. 2002 Aug;24(4):225-32.

PMID:
12181026
4.

Evaluation of platelet function with the PFA-100 system in patients with congenital defects of platelet secretion.

Cattaneo M, Lecchi A, Agati B, Lombardi R, Zighetti ML.

Thromb Res. 1999 Nov 1;96(3):213-7.

PMID:
10588464
5.

Usefulness of the INNOVANCE PFA P2Y test cartridge for the detection of patients with congenital defects of the platelet P2Y₁₂ receptor for adenosine diphosphate.

Scavone M, Germanovich K, Femia EA, Cattaneo M.

Thromb Res. 2014 Feb;133(2):254-6. doi: 10.1016/j.thromres.2013.11.022. Epub 2013 Dec 1.

PMID:
24331208
6.

Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA.

McCabe DJ, Harrison P, Mackie IJ, Sidhu PS, Lawrie AS, Purdy G, Machin SJ, Brown MM.

Platelets. 2005 Aug;16(5):269-80.

PMID:
16011977
8.

PFA-100 system: a new method for assessment of platelet dysfunction.

Mammen EF, Comp PC, Gosselin R, Greenberg C, Hoots WK, Kessler CM, Larkin EC, Liles D, Nugent DJ.

Semin Thromb Hemost. 1998;24(2):195-202.

PMID:
9579642
9.

The effect of antiplatelet drugs, heparin, and preanalytical variables on platelet function detected by the platelet function analyzer (PFA-100).

Kottke-Marchant K, Powers JB, Brooks L, Kundu S, Christie DJ.

Clin Appl Thromb Hemost. 1999 Apr;5(2):122-30.

PMID:
10725993
10.

Description of an in vitro platelet function analyzer--PFA-100.

Kundu SK, Heilmann EJ, Sio R, Garcia C, Davidson RM, Ostgaard RA.

Semin Thromb Hemost. 1995;21 Suppl 2:106-12.

PMID:
7660150
11.

von Willebrand disease in a pediatric-based population--comparison of type 1 diagnostic criteria and use of the PFA-100 and a von Willebrand factor/collagen-binding assay.

Dean JA, Blanchette VS, Carcao MD, Stain AM, Sparling CR, Siekmann J, Turecek PL, Lillicrap D, Rand ML.

Thromb Haemost. 2000 Sep;84(3):401-9.

PMID:
11019962
12.

External quality assessment/proficiency testing and internal quality control for the PFA-100 and PFA-200: an update.

Favaloro EJ, Bonar R.

Semin Thromb Hemost. 2014 Mar;40(2):239-53. doi: 10.1055/s-0034-1365844. Epub 2014 Feb 4. Review.

PMID:
24497116
13.
14.

Platelet dysfunction in primary thrombocythemia using the platelet function analyzer, PFA-100.

Cesar JM, de Miguel D, García Avello A, Burgaleta C.

Am J Clin Pathol. 2005 May;123(5):772-7.

PMID:
15981818
15.

Use of the PFA-100 in the assessment of primary, platelet-related hemostasis in a pediatric setting.

Rand ML, Carcao MD, Blanchette VS.

Semin Thromb Hemost. 1998;24(6):523-9. Review.

PMID:
10066147
16.
17.

Role of platelet membrane glycoproteins Ib/IX and IIb/IIIa, and of platelet alpha-granule proteins in platelet aggregation induced by human osteosarcoma cells.

Clezardin P, Drouin J, Morel-Kopp MC, Hanss M, Kehrel B, Serre CM, Kaplan C, Delmas PD.

Cancer Res. 1993 Oct 1;53(19):4695-700.

PMID:
7691402
19.

Evaluation of the PFA-100 system in the diagnosis and therapeutic monitoring of patients with von Willebrand disease.

Cattaneo M, Federici AB, Lecchi A, Agati B, Lombardi R, Stabile F, Bucciarelli P.

Thromb Haemost. 1999 Jul;82(1):35-9.

PMID:
10456451
20.

Comparison of PFA-100 testing and bleeding time for detecting platelet hypofunction and von Willebrand disease in clinical practice.

Posan E, McBane RD, Grill DE, Motsko CL, Nichols WL.

Thromb Haemost. 2003 Sep;90(3):483-90.

PMID:
12958618

Supplemental Content

Support Center